Abstract
Understanding how proteins protect themselves from aberrant aggregation is of primary interest for understanding basic biology, protein biochemistry, and human disease. We discuss the paradigmatic example of ataxin-1 (Atx1), the protein responsible for neurodegenerative spinocerebellar ataxia type 1 (SCA1). This disease is part of the increasing family of pathologies caused by protein aggregation and misfolding. We discuss the importance of protein-protein interactions not only in the nonpathological function of Atx1 but also in protecting the protein from aggregation and misfolding. The lessons learned from Atx1 may lead to a more general understanding of the cell's protective strategies against aggregation. The obtained knowledge may suggest a new perspective for designing specific therapeutic strategies for the cure of misfolding diseases.
Original language | English |
---|---|
Pages (from-to) | 211-218 |
Number of pages | 8 |
Journal | Trends in Neurosciences |
Volume | 37 |
Issue number | 4 |
DOIs | |
Publication status | Published - Apr 2014 |
Keywords
- misfolding diseases
- polyglutamine
- protein aggregation
- protein-protein interactions
- POLYGLUTAMINE DISEASE PROTEIN
- SCA1 TRANSGENIC MICE
- SPINOCEREBELLAR ATAXIA
- AXH DOMAIN
- NEURODEGENERATIVE DISEASE
- FUNCTIONAL INTERACTIONS
- 14-3-3 BINDING
- IDENTIFICATION
- TYPE-1
- GENES